Articles related to DEPRESSION

Stay ahead in your practice by exploring the potential of GLP-1 Receptor Agonists (GLP-1RAs) as a new treatment option for depressive symptoms.

Discover how esketamine nasal spray could significantly alter the treatment approach for patients suffering from treatment-resistant depression.

Discover how Exxua, the newly FDA-approved antidepressant, could be a game-changer in treating major depressive disorder, backed by robust clinical trials and a manageable side effect profile.

Gain insights into the challenges and nuances of diagnosing and treating Depressive Mixed States, a newly classified condition that requires a specialized approach for effective management.

Explore the paradigm shift in depression treatment from chemical imbalances to neuroplasticity, and discover how this emerging concept could revolutionize therapeutic approaches.

Explore how a paradigm shift from monoamine to GABAergic systems could offer new, more effective treatments for major depressive disorder; the latest review discusses the unmet needs and the promising potential of NAS GABAA receptor PAMs.